Company Novavax, Inc. Nasdaq
Equities
US6700021040
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Vaccines
100.0
%
| 1,982 | 100.0 % | 984 | 100.0 % | -50.36% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,982 | 100.0 % | 984 | 100.0 % | -50.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Jacobs
CEO | Chief Executive Officer | 57 | 23/23/23 |
John Trizzino
PSD | President | 64 | 10/14/10 |
James Kelly
DFI | Director of Finance/CFO | 58 | 16/21/16 |
Troy Morgan
CMP | Compliance Officer | - | 19/21/19 |
Raburn Mallory
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Seth Toback
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Gale Smith
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/01 |
Filip Dubovsky
CTO | Chief Tech/Sci/R&D Officer | 59 | 17/20/17 |
Biegie Lee
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Silvia Taylor
IRO | Public Communications Contact | - | 17/20/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rodgers
BRD | Director/Board Member | 57 | 29/22/29 |
Gregg Alton
BRD | Director/Board Member | 58 | 01/20/01 |
David Mott
BRD | Director/Board Member | 58 | 16/20/16 |
James Young
CHM | Chairman | 71 | 07/10/07 |
Margaret McGlynn
BRD | Director/Board Member | 64 | 07/20/07 |
Rachel King
BRD | Director/Board Member | 64 | 01/18/01 |
Richard Douglas
BRD | Director/Board Member | 71 | 06/10/06 |
John Jacobs
CEO | Chief Executive Officer | 57 | 23/23/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 140,953,466 | 132,964,447 ( 94.33 %) | 1,000,323 ( 0.7097 %) | 94.33 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |